Invention Grant
- Patent Title: Methods of cloning nucleic acids or producing proteins in a low endotoxin organism
-
Application No.: US17212926Application Date: 2021-03-25
-
Publication No.: US11746321B2Publication Date: 2023-09-05
- Inventor: Matthew T Weinstock , Daniel G. Gibson , Daniel Strimling
- Applicant: Codex DNA, Inc.
- Applicant Address: US CA San Diego
- Assignee: Telesis Bio Inc.
- Current Assignee: Telesis Bio Inc.
- Current Assignee Address: US CA San Diego
- Agency: DLA Piper LLP (US)
- The original application number of the division: US16154618 2018.10.08
- Main IPC: C12N1/20
- IPC: C12N1/20 ; C12N15/74 ; C12N9/10 ; C12R1/63

Abstract:
The invention provides engineered Vibrio sp. organisms that comprise a genetic modification to either or both of the lpxL and/or lpxM genes. The organisms score substantially lower in an in vitro endotoxin assay versus the unmodified or wild type organism. The organisms preserve substantially the growth rate of the corresponding unmodified organisms. The organisms can also have an exogenous nucleic acid cloned in the organism, or an exogenous nucleic acid encoding a protein, polypeptide, or peptide expressed by the organism, and optionally secreted from the organism.
Public/Granted literature
- US20210284954A1 VIBRIO SP. ORGANISMS WITH MODIFIED LIPOPOLYSACCHARIDE Public/Granted day:2021-09-16
Information query
IPC分类: